U.S. Building Stock News

SunocoCorp stock: context for the recent move SunocoCorp (SUNC) has drawn attention after a recent share price move, with the stock closing at $56.47. Short term returns over the past week, month, and past 3 months give investors fresh data to reassess the name. See our latest analysis for SunocoCorp. The recent 2.45% single-day share price return, together with a 7.24% three-month share price return and a 15.20% year-to-date share price return, suggests that momentum has been building rather...

Bristol-Myers Squibb Company ( NYSE:BMY ) announced a healthy earnings result recently, and the market rewarded it with...

The Morning Bull - US Market Morning Update Wednesday, Feb, 18 2026 US stock futures are pointing higher this morning, with contracts tied to the S&P 500 up about 0.5% and Nasdaq 100 futures up just over 0.5%. The backdrop is a global slide in government bond yields after softer inflation in the UK, where price growth eased to 3.0%, and in Canada at 2.3%, which investors read as central banks being closer to cutting interest rates. At the same time, US bond yields sit near 4.06% ahead of...

Despite announcing strong earnings, Vertex, Inc.'s ( NASDAQ:VERX ) stock was sluggish. Our analysis uncovered some...

HubSpot, Inc.'s ( NYSE:HUBS ) strong earnings report was rewarded with a positive stock price move. We did some digging...

Anterix Inc.'s ( NASDAQ:ATEX ) stock performed strongly after the recent earnings report. However, we think that...

In the last year, multiple insiders have substantially increased their holdings of aTyr Pharma, Inc. ( NASDAQ:ATYR...

Q2 Holdings, Inc.'s ( NYSE:QTWO ) earnings announcement last week was disappointing for investors, despite the decent...

Some Yum China Holdings, Inc. ( NYSE:YUMC ) shareholders may be a little concerned to see that the CEO & Executive...

Some TTM Technologies, Inc. ( NASDAQ:TTMI ) shareholders may be a little concerned to see that the Director, Thomas...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Wondering if Resolute Holdings Management is starting to offer value at its current share price, or if it still looks fully priced? This article walks through the key signals that matter. The stock last closed at US$179.59, after a 7 day return of an 11.6% decline and a 30 day return of a 13.0% decline, while the year to date return sits at a 3.7% decline. All of these moves can influence how investors think about both upside and risk today. Recent coverage of Resolute Holdings Management...

If you are looking at Select Water Solutions and wondering whether the current price reflects its true worth, this article will walk through what the numbers are actually saying about the stock. The share price last closed at US$13.26, with returns of 4.2% over 7 days, 12.2% over 30 days, 19.6% year to date, 1.8% over 1 year, 79.7% over 3 years, and 120.8% over 5 years. This gives useful context before comparing that price to estimates of value. Recent news around Select Water Solutions has...

Monolithic Power Systems (NasdaqGS:MPWR) announced the retirement of Chief Financial Officer and Executive Vice President Bernie Blegen after a decade in executive roles. Long-time Corporate Controller Rob Dean has been promoted to interim CFO, marking an internal succession within the finance team. The leadership change highlights a transition at the top of the company’s financial function while the board considers longer term plans for the role. Monolithic Power Systems focuses on analog...

Daily Journal's Q1 2026 Results In Focus Daily Journal (DJCO) opened fiscal 2026 with Q1 revenue of US$19.5 million and a basic EPS loss of US$5.79, against trailing 12 month EPS of US$67.70 on revenue of US$89.5 million, which has been influenced by a one off gain of US$109.2 million over the past year. The company has seen quarterly revenue move from US$17.7 million in Q1 2025 to US$19.5 million in Q1 2026, while trailing 12 month EPS has shifted from US$55.48 to US$67.70 and net income...

In recent weeks, Ark Invest has steadily accumulated shares of cryptocurrency exchange Bullish, purchasing about US$58.75 million across ten consecutive trading days. This persistent buying coincides with Bullish securing a New York BitLicense and highlighting more than US$1.50 trillion in cumulative trading volume, underscoring its focus on large professional clients. Next, we’ll examine how Ark Invest’s repeated Bullish purchases shape the company’s investment narrative and perceived...

Seanergy Maritime Holdings (NasdaqCM:SHIP) has wrapped up FY 2025 with fourth quarter revenue of US$49.4 million and basic EPS of US$0.60, capping a year in which trailing twelve month revenue came in at US$158.1 million and EPS at US$1.04. Over recent periods, revenue has moved from US$41.7 million in Q4 2024 to US$49.4 million in Q4 2025. Quarterly EPS shifted from US$0.25 to US$0.60, alongside trailing twelve month net income of US$21.2 million. With trailing net profit margin sitting at...

Evergy entered into a new $500 million unsecured term loan agreement that replaces a smaller prior facility. The company plans to use the facility for capital expenditures, acquisitions, and repayment of existing debt. The new loan provides fresh funding capacity that could influence Evergy’s capital allocation and balance sheet structure. For investors watching NasdaqGS:EVRG, this financing move comes with the stock trading at $81.51 and showing returns of 3.5% over the past week and 6.6%...

Ceragon Networks (NasdaqGS:CRNT) has wrapped up FY 2025 with fourth quarter revenue of US$82.3 million and basic EPS of about US$0.001, alongside net income of roughly US$0.1 million. This keeps the full year on a trailing 12 month loss of US$2.1 million, or EPS of about US$0.02. The company has seen quarterly revenue range from US$88.7 million in Q1 2025 to US$82.3 million in Q4 2025, while basic EPS moved from a loss of about US$0.01 in the first half to small positive readings of roughly...

Walker & Dunlop (NYSE:WD) arranged a major ESG-focused refinancing for the Zuiderpoort office complex in Ghent, Belgium. The financing supports plans to upgrade the property, including a fossil fuel free HVAC system and other sustainability measures. The deal highlights the company’s role in cross border real estate financing and activity in Europe’s green property market. For you as an investor following Walker & Dunlop, this deal sits within the company’s core business of real estate...

Latest FY 2025 Results Set the Stage for eToro Group (ETOR) eToro Group (ETOR) has put fresh numbers on the board for FY 2025, with fourth quarter revenue of about US$3.9b and basic EPS of US$0.79, alongside full year trailing twelve month EPS of US$2.58 on revenue of roughly US$13.8b. The company has seen quarterly revenue move from US$5.8b in Q4 2024 to US$3.9b in Q4 2025, while basic EPS shifted from US$0.78 to US$0.79 over the same period. Trailing twelve month revenue has ranged between...

Medtronic (MDT) has reported Q3 2026 results with total revenue of US$9.0b, basic EPS of US$0.89 and net income excluding extra items of US$1,143m, with trailing twelve month EPS at US$3.60 on revenue of US$35.5b. The company has seen quarterly revenue move from US$8.3b in Q3 2025 to US$9.0b in Q3 2026, while basic EPS over that span has ranged between US$0.81 and US$1.07. This sets the backdrop for earnings growth of 8.3% over the last year and a modestly higher net margin of 13%. Taken...

National Energy Services Reunited (NasdaqCM:NESR) has reported fourth quarter FY 2025 revenue of US$398.3 million with basic EPS of US$0.08, setting the tone for a year where trailing twelve month revenue came in at about US$1.3 billion and EPS at US$0.52. The company has seen quarterly revenue move from US$343.7 million in Q4 2024 to US$398.3 million in Q4 2025, while basic EPS shifted from US$0.28 to US$0.08 over the same period. This gives investors a clear view of the trade off between...

Harmony Biosciences Holdings (NasdaqGM:HRMY) received FDA approval for WAKIX (pitolisant) tablets to treat cataplexy in pediatric patients with narcolepsy. The decision expands WAKIX into pediatric use and makes it the first and only non scheduled treatment option across both pediatric and adult patients, with or without cataplexy. The company is also pursuing pediatric exclusivity for WAKIX, which could influence its position in this indication. For investors watching Harmony Biosciences...